106 related articles for article (PubMed ID: 10025891)
1. Enhanced expression of p16ink4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia.
Mekki Y; Catallo R; Bertrand Y; Manel AM; Ffrench P; Baghdassarian N; Duhaut P; Bryon PA; Ffrench M
Leukemia; 1999 Feb; 13(2):181-9. PubMed ID: 10025891
[TBL] [Abstract][Full Text] [Related]
2. Role of BCL-2 and cell cycle regulatory proteins for corticosensitivity assessment in childhood acute lymphoblastic leukaemia.
Baghdassarian N; Bertrand Y; Ffrench P; Duhaut P; Bryon PA; Ffrench M
Br J Haematol; 2000 Apr; 109(1):109-16. PubMed ID: 10848789
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p16INK4A) in childhood acute lymphoblastic leukemia.
Volm M; Koomägi R; Stammler G; Rittgen W; Zintl F; Sauerbrey A
Int J Cancer; 1997 Oct; 74(5):508-12. PubMed ID: 9355972
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
6. [Expression of p16INK4a, p15INK4b, p21WAF1/Clip1 cell cycle inhibitors on blastic cells in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) ].
Kapelko-Słowik K; Wołowiec D; Sedek K; Jaźwiec B; Urbaniak-Kujda D; Kuliczkowski K
Pol Arch Med Wewn; 2002 Sep; 108(3):849-53. PubMed ID: 12600181
[TBL] [Abstract][Full Text] [Related]
7. The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome.
Chien WW; Catallo R; Chebel A; Baranger L; Thomas X; Béné MC; Gerland LM; Schmidt A; Beldjord K; Klein N; Escoffre-Barbe M; Leguay T; Huguet F; Larosa F; Hayette S; Plesa A; Ifrah N; Dombret H; Salles G; Chassevent A; Ffrench M
Leuk Res; 2015 Apr; 39(4):453-61. PubMed ID: 25675863
[TBL] [Abstract][Full Text] [Related]
8. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of p16INK4a immunocytochemistry in adult ALL with standard risk karyotype.
Soenen V; Lepelley P; Gyan E; Preudhomme C; Lai JL; Bauters F; Fenaux P; Quesnel B
Leukemia; 2001 Jul; 15(7):1054-9. PubMed ID: 11455973
[TBL] [Abstract][Full Text] [Related]
10. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
11. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias.
Delmer A; Tang R; Senamaud-Beaufort C; Paterlini P; Brechot C; Zittoun R
Leukemia; 1995 Jul; 9(7):1240-5. PubMed ID: 7630199
[TBL] [Abstract][Full Text] [Related]
12. Deletion of one copy of the p16INK4A tumor suppressor gene is implicated as a predisposing factor in pediatric leukemia.
Carter TL; Terry P; Gottardo N; Baker DL; Kees UR; Watt PM
Biochem Biophys Res Commun; 2004 Jun; 318(4):852-5. PubMed ID: 15147949
[TBL] [Abstract][Full Text] [Related]
13. p16ink4a gene and hematological malignancies.
Quesnel B; Preudhomme C; Fenaux P
Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of T-cell acute lymphoblastic leukemia proliferation in vivo by re-expression of the p16INK4a tumor suppressor gene.
Schoppmeyer K; Norris PS; Haas M
Neoplasia; 1999 Jun; 1(2):128-37. PubMed ID: 10933047
[TBL] [Abstract][Full Text] [Related]
15. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations.
Maloney KW; McGavran L; Odom LF; Hunger SP
Leukemia; 1998 Sep; 12(9):1417-21. PubMed ID: 9737691
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation.
Kaddar T; Chien WW; Bertrand Y; Pages MP; Rouault JP; Salles G; Ffrench M; Magaud JP
Leuk Res; 2009 Sep; 33(9):1217-23. PubMed ID: 19195700
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 expression and prognosis in childhood acute leukemia. Children's Cancer and Leukemia Study Group.
Tsurusawa M; Saeki K; Katano N; Fujimoto T
Pediatr Hematol Oncol; 1998; 15(2):143-55. PubMed ID: 9592841
[TBL] [Abstract][Full Text] [Related]
18. In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia.
Ramakers-van Woerden NL; Pieters R; Slater RM; Loonen AH; Beverloo HB; van Drunen E; Heyman M; Moreno TC; Rots MG; van Wering ER; Kamps WA; Janka-Schaub GE; Veerman AJ
Br J Haematol; 2001 Mar; 112(3):680-90. PubMed ID: 11260073
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of growth of human leukemia cell lines by retrovirally expressed wild-type p16INK4A.
Gombart AF; Yang R; Campbell MJ; Berman JD; Koeffler HP
Leukemia; 1997 Oct; 11(10):1673-80. PubMed ID: 9324288
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
